VISTA
Anualidades
Lista
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
TOTAL Nº PUBLICACIONES:
12
PUBLICACIONES EN REVISTAS
Botta, Cirino, Perez, Cristina, Larrayoz, Marta, Puig, Noemi, Cedena, Maria-Teresa, Termini, Rosalinda, Goicoechea, Ibai, Rodriguez, Sara, Zabaleta, Aintzane, Lopez, Aitziber, Sarvide, Sarai, Blanco, Laura, Papetti, Daniele M., Nobile, Marco S., Besozzi, Daniela, Gentile, Massimo, Correale, Pierpaolo, Siragusa, Sergio, Oriol, Albert, Gonzalez-Garcia, Maria Esther, Sureda, Anna, de Arriba, Felipe, Rios Tamayo, Rafael, Moraleda, Jose-Maria, Gironella, Mercedes, Hernandez, Miguel T., Bargay, Joan, Palomera, Luis, Perez-Montana, Albert, Goldschmidt, Hartmut, Avet-Loiseau, Herve, Roccaro, Aldo, Orfao, Alberto, Martinez-Lopez, Joaquin, Rosinol, Laura, Lahuerta, Juan-Jose, Blade, Joan, Mateos, Maria-Victoria, San-Miguel, Jesus F., Martinez Climent, Jose-Angel, Paiva, Bruno, Programa Para Estudio Terapeut.
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
NAT COMMUN 14 -. 20 sep 2023. . . F.I.:16,600
[doi:10.1038/s41467-023-41562-6]
Alejo, Elena, Puertas, Borja, Agullo, Cristina, Rey-Bua, Beatriz, Garcia-Sanz, Ramon, Puig, Noemi, Mateos, Maria-Victoria, Gonzalez-Calle, Veronica.
Clinical characteristics and risk of progression in patients with monoclonal gammopathy of uncertain significance: long-term experience in a single tertiary hospital.
CL LYMPH MYELOM LEUK 23 84-84. 1 sep 2023. . . F.I.:2,700
Rodriguez-Otero, Paula, Gonzalez-Calle, Veronica, Calasanz, Maria-Jose, Cedena, Teresa, Puig, Noemi, Martinez-Lopez, Joaquin, Rosinol, Laura, Hernandez Garcia, Miguel Teodoro, Isabel Teruel, Ana, Gironella, Mercedes, Oriol, Albert, de la Rubia, Javier, Pilar Gonzalez-Rodriguez, Ana, Bargay, Joan, de Arriba de la Fuente, Felipe, Palomera, Luis, Gonzalez-Perez, Marta-Sonia, Sureda Balari, Anna, Lahuerta Palacios, Juan Jose, Blade, Joan, San-Miguel, Jesus, Mateos, Maria-Victoria, Gutierrez, Norma.
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience.
CL LYMPH MYELOM LEUK 23 241-242. 1 sep 2023. . . F.I.:2,700
Guerrero, Camila, Puig, Noemi, Cedena, Teresa, Calasanz, Maria-Jose, Gutierrez, Norma, Fernandez-Guijarro, Manuela, Oriol, Albert, Rios, Rafael, Hernandez Garcia, Miguel Teodoro, Martinez-Martinez, Rafael, Bargay, Joan, de Arriba de la Fuente, Felipe, Palomera, Luis, Pilar Gonzalez-Rodriguez, Ana, Gonzalez-Perez, Marta-Sonia, Orfao, Alberto, Mateos, Maria-Victoria, Martinez-Lopez, Joaquin, Rosinol, Laura, Blade, Joan, Lahuerta Palacios, Juan Jose, San-Miguel, Jesus, Paiva, Bruno.
Predictors of unsustained measurable residual disease (MRD) negativity in transplant-eligible multiple myeloma (MM) patients.
CL LYMPH MYELOM LEUK 23 7-8. 1 sep 2023. . . F.I.:2,700
Puertas, B, Alejo, E, Rey-Búa, B, Dosantos, Y, Redondo, E, Real, I, Prieto, L, Ubeda, SG, Sánchez, AH, Corral, LL, Garcia-Sanz, R, Puig, N, Gonzalez-Calle, V, Mateos, MV.
Triple class refractory multiple myeloma: eficacy of the new immunotherapies and new unmet medical need.
CL LYMPH MYELOM LEUK 23 205-206. 1 sep 2023. . . F.I.:2,700
Cardenas, MC, Garcia-Sanz, R, Puig, N, Perez-Surribas, D, Flores-Montero, J, Ortiz-Espejo, M, de la Rubia, J, Cruz-Iglesias, E.
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: update on laboratory tests for the study of monoclonal gammopathies.
CLIN CHEM LAB MED 61 2115-2130. 24 jul 2023. 1 jul 2023. . F.I.:6,800
[doi:10.1515/cclm-2023-0326]
Cardenas, MC, Garcia-Sanz, R, Puig, N, Perez-Surribas, D, Flores-Montero, J, Ortiz-Espejo, M, de la Rubia, J, Cruz-Iglesias, E.
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies.
CLIN CHEM LAB MED 61 2131-2142. 4 jul 2023. 1 jul 2023. . F.I.:6,800
[doi:10.1515/cclm-2023-0325]
Medina-Herrera, A, Sarasquete, ME, Jimenez, C, Puig, N, Garcia-Sanz, R.
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future.
CANCERS 15 -. 1 jul 2023. . . F.I.:5,200
[doi:10.3390/cancers15143687]
Burgos, L, Tamariz-Amador, LE, Puig, N, Cedena, MT, Guerrero, C, Jelinek, T, Johnson, S, Milani, P, Cordon, L, Perez, JJ, Lasa, M, Termini, R, Oriol, A, Hernandez, MT, Palomera, L, Martinez-Martinez, R, de la Rubia, J, de Arriba, F, Rios, R, Gonzalez, ME, Gironella, M, Cabanas, V, Casanova, M, Krsnik, I, Perez-Montana, A, Gonzalez-Calle, V, Rodriguez-Otero, P, Maisnar, V, Hajek, R, Van Rhee, F, Jimenez-Zepeda, V, Palladini, G, Merlini, G, Orfao, A, de la Cruz, J, Martinez-Lopez, J, Lahuerta, JJ, Rosinol, L, Blade, J, Mateos, MV, San-Miguel, JF, Paiva, B.
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
J CLIN ONCOL 41 3019-3019. 1 jun 2023. . . F.I.:45,400
[doi:10.1200/JCO.22.01916]
Puertas, B, Gonzalez-Calle, V, Sobejano-Fuertes, E, Escalante, F, Rey-Bua, B, Padilla, I, Garcia-Sanz, R, Puig, N, Gutierrez, NC, Mateos, MV.
Multiple myeloma with t(11;14): impact of novel agents on outcome.
BLOOD CANCER J 13 -. 20 mar 2023. . . F.I.:12,800
[doi:10.1038/s41408-023-00807-9]
Previous
1
2
Next
Nº de Artículos por página:
10
25
50
100